| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $-0.2B | $0.2B | $0.2B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.64 | $-1.17 | $1.43 | $1.46 | $2.77 | — | — | — |
| EPS (Diluted) | $0.64 | $-1.17 | $1.43 | $1.46 | $2.77 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.0B | $19.8B | $24.0B | $25.4B | $22.7B | $17.0B | $16.6B | $14.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.3B | $0.4B | $0.3B | $0.6B | $0.3B | $0.2B | $0.1B |
| Total Liabilities | $16.5B | $16.0B | $19.6B | $20.8B | $18.1B | $13.1B | $12.8B | $11.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.5B | $3.8B | $4.4B | $4.5B | $4.6B | $3.9B | $3.8B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Investing Cash Flow | $0.4B | $3.5B | $1.4B | $-3.3B | $-5.6B | $-0.1B | $-1.9B | $-4.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-3.9B | $-1.8B | $2.6B | $5.5B | $-0.1B | $1.6B | $4.0B |